您的位置: 首页 > 农业专利 > 详情页

PATIENT SELECTIVE APHERESIS
专利权人:
INC.;ELIAZ THERAPEUTICS
发明人:
Isaac ELIAZ
申请号:
US15081978
公开号:
US20160279314A1
申请日:
2016.03.28
申请国别(地区):
US
年份:
2016
代理人:
摘要:
A system and method for the practice of apheresis employs modules in the system which can be selected for a particular patient to treat particular situations or combinations of difficulties. In one example, Gal-3 mediates a large number of body reactions, and is an effective protector of tumor microenvironments and the like, as well inflammation driver. Removal of Gal-3 may make antic-cancer treatments, like photopheresis and TNF administration more effective. Separate modules, such as one for photopheresis and one for TNF receptor removal, may be combined with a module for the reduction of Gal-3, to render the combination of treatments each more effective than if administered alone.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充